至 2040 年全球胰腺癌发病率趋势:疾病-死亡模型研究 "的更正。

IF 2.9 2区 医学 Q2 ONCOLOGY
Cancer Medicine Pub Date : 2024-11-18 DOI:10.1002/cam4.70417
{"title":"至 2040 年全球胰腺癌发病率趋势:疾病-死亡模型研究 \"的更正。","authors":"","doi":"10.1002/cam4.70417","DOIUrl":null,"url":null,"abstract":"<p>Hesami Z, Olfatifar M, Sadeghi A, Zali MR, Mohammadi-Yeganeh S, Habibi MA, Ghadir MR, Houri H. Global Trend in Pancreatic Cancer Prevalence Rates Through 2040: An Illness-Death Modeling Study. <i>Cancer Med</i>. 2024 Oct;13(20):e70318. https://doi.org/10.1002/cam4.70318</p><p>The Ethical Code Acknowledgment is missing in the published paper. The Ethics Statement, “This project has been ethically approved by the Ethics Committee at Qom University of Medical Sciences, Qom, Iran (No. IR.MUQ.REC.1402.186).” should be placed after the Acknowledgment section.</p><p>We apologize for this error.</p>","PeriodicalId":139,"journal":{"name":"Cancer Medicine","volume":"13 22","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cam4.70417","citationCount":"0","resultStr":"{\"title\":\"Correction to “Global Trend in Pancreatic Cancer Prevalence Rates Through 2040: An Illness-Death Modeling Study”\",\"authors\":\"\",\"doi\":\"10.1002/cam4.70417\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Hesami Z, Olfatifar M, Sadeghi A, Zali MR, Mohammadi-Yeganeh S, Habibi MA, Ghadir MR, Houri H. Global Trend in Pancreatic Cancer Prevalence Rates Through 2040: An Illness-Death Modeling Study. <i>Cancer Med</i>. 2024 Oct;13(20):e70318. https://doi.org/10.1002/cam4.70318</p><p>The Ethical Code Acknowledgment is missing in the published paper. The Ethics Statement, “This project has been ethically approved by the Ethics Committee at Qom University of Medical Sciences, Qom, Iran (No. IR.MUQ.REC.1402.186).” should be placed after the Acknowledgment section.</p><p>We apologize for this error.</p>\",\"PeriodicalId\":139,\"journal\":{\"name\":\"Cancer Medicine\",\"volume\":\"13 22\",\"pages\":\"\"},\"PeriodicalIF\":2.9000,\"publicationDate\":\"2024-11-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cam4.70417\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cam4.70417\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cam4.70417","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

Hesami Z、Olfatifar M、Sadeghi A、Zali MR、Mohammadi-Yeganeh S、Habibi MA、Ghadir MR、Houri H.《2040 年全球胰腺癌患病率趋势:疾病-死亡模型研究》。Cancer Med.2024 Oct;13(20):e70318. https://doi.org/10.1002/cam4.70318The 发表的论文中缺少伦理规范致谢。伦理声明 "本项目已获得伊朗库姆市库姆医科大学伦理委员会的伦理批准(编号:IR.MUQ.REC.1402.186)"应放在致谢部分之后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Correction to “Global Trend in Pancreatic Cancer Prevalence Rates Through 2040: An Illness-Death Modeling Study”

Hesami Z, Olfatifar M, Sadeghi A, Zali MR, Mohammadi-Yeganeh S, Habibi MA, Ghadir MR, Houri H. Global Trend in Pancreatic Cancer Prevalence Rates Through 2040: An Illness-Death Modeling Study. Cancer Med. 2024 Oct;13(20):e70318. https://doi.org/10.1002/cam4.70318

The Ethical Code Acknowledgment is missing in the published paper. The Ethics Statement, “This project has been ethically approved by the Ethics Committee at Qom University of Medical Sciences, Qom, Iran (No. IR.MUQ.REC.1402.186).” should be placed after the Acknowledgment section.

We apologize for this error.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cancer Medicine
Cancer Medicine ONCOLOGY-
CiteScore
5.50
自引率
2.50%
发文量
907
审稿时长
19 weeks
期刊介绍: Cancer Medicine is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences. The journal will consider submissions from all oncologic specialties, including, but not limited to, the following areas: Clinical Cancer Research Translational research ∙ clinical trials ∙ chemotherapy ∙ radiation therapy ∙ surgical therapy ∙ clinical observations ∙ clinical guidelines ∙ genetic consultation ∙ ethical considerations Cancer Biology: Molecular biology ∙ cellular biology ∙ molecular genetics ∙ genomics ∙ immunology ∙ epigenetics ∙ metabolic studies ∙ proteomics ∙ cytopathology ∙ carcinogenesis ∙ drug discovery and delivery. Cancer Prevention: Behavioral science ∙ psychosocial studies ∙ screening ∙ nutrition ∙ epidemiology and prevention ∙ community outreach. Bioinformatics: Gene expressions profiles ∙ gene regulation networks ∙ genome bioinformatics ∙ pathwayanalysis ∙ prognostic biomarkers. Cancer Medicine publishes original research articles, systematic reviews, meta-analyses, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented in the paper.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信